GSK-Bharat, Dr. Reddy's, Sandoz and more—FiercePharmaAsia by Angus Liu Friday, February 22, 2019 GSK sells Indian vaccine subsidiary to Bharat; Dr. Reddy's rides a turbulent week; Sandoz sells more U.S. generics.
GSK sells Indian vaccine unit to Bharat Biotech by Angus Liu Friday, February 15, 2019 After the buy, Bharat Biotech will be able to make 25 million doses of rabies vaccine each year, its chairman said.
Valneva scores quick FDA review for chikungunya vaccine by Eric Sagonowsky Wednesday, January 2, 2019 The FDA fast-tracked Valneva's shot against chikungunya, a disease with no approved vaccines.
FDA places PaxVax's phase 2 chikungunya shot on its fast track by Eric Sagonowsky Tuesday, May 8, 2018 PaxVax picked up the FDA's fast track tag for its chikungunya vaccine.
BMS' cancer vaccine, Bharat Biotech and more—News of Note by Angus Liu Wednesday, April 4, 2018 Here's some other vaccine news of note for the week.
FiercePharmaAsia—Lantus biosimilar, Takeda, Celltrion by Angus Liu Friday, February 2, 2018 Mylan and Biocon win CHMP nod for a Lantus biosimilar, Takeda's Zika vaccine fast-tracked by the FDA, Celltrion got a warning letter.
Bharat Biotech picks up WHO prequalification for Rotavac by Eric Sagonowsky Tuesday, January 30, 2018 Ready to challenge GlaxoSmithKline and Merck, India's Bharat Biotech has won WHO prequalification for its rotavirus vaccine Rotavac.
Dynavax’s Heplisav-B, Emergent and more—News of Note by Angus Liu Wednesday, January 10, 2018 Here is some other vaccine news of note for the week.
FiercePharmaAsia—Dr. Reddy’s, CanSino and more by Angus Liu Friday, October 27, 2017 Dr. Reddy's recalls more meds in the U.S., while the EMA recanted its plant's GMP certificate; China approved a domestic Ebola vaccine.
Bharat's typhoid vaccine can be used in young children: WHO by Angus Liu Tuesday, October 24, 2017 No currently available vaccines against typhoid are meant for children younger than 2, but a new WHO endorsement could change that.
